Around 5-7% of breast cancer is considered "hereditary" due to the presence of germline mutations that confer a significant risk of developing breast cancer. Currently identified two major genes responsible for this susceptibility are BRCA1 and BRCA2.
Knowing the risk of developing a breast cancer one can make the best decision in terms of surveillance or pursue a course of preventive care.
The test is performed on NGS platform in 7 working days starting from a blood sample (2 EDTA tubes).
Documents: informed consent, information notice, consent to privacy, request form, sample collection and shipping instructions.